17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Modulation of the CB2 receptor is an interesting approach for pain and inflammation, arthritis, addictions, neuroprotection, and cancer, among other possible therapeutic applications, and is devoid of central side effects.

          Related collections

          Author and article information

          Journal
          Expert Opin Ther Pat
          Expert opinion on therapeutic patents
          Informa UK Limited
          1744-7674
          1354-3776
          Jul 2016
          : 26
          : 7
          Affiliations
          [1 ] a Instituto de Química Médica , Consejo Superior de Investigaciones Científicas , Madrid , Spain.
          Article
          10.1080/13543776.2016.1193157
          27215781
          fc71ad3d-aac9-4192-b5ba-a72ff6ae2767
          History

          cancer,HIV,Cannabinoid receptor 2,pain,osteoarthritis,organ transplant,inflammation,endometriosis

          Comments

          Comment on this article